Involvement of the PI3K/Akt pathway in myxoid/round cell liposarcoma
Open Access
- 21 October 2011
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 25 (2), 212-221
- https://doi.org/10.1038/modpathol.2011.148
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Mechanisms of Disease: signaling of the insulin-like growth factor 1 receptor pathway—therapeutic perspectives in cancerNature Clinical Practice Oncology, 2007
- Clinicopathologic Prognostic Factors in Myxoid Liposarcoma: A Retrospective Study of 49 Patients With Long-Term Follow-UpAnnals of Surgical Oncology, 2006
- Expression of the FUS-CHOP Fusion Protein in Primary Mesenchymal Progenitor Cells Gives Rise to a Model of Myxoid LiposarcomaCancer Research, 2006
- The PIK3CA gene is mutated with high frequency in human breast cancersCancer Biology & Therapy, 2004
- Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.2001
- Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcomaOncogene, 2000
- Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein.1997
- The clinicopathologic spectrum of myxoid and round cell liposarcoma: A study of 95 casesCancer, 1996
- Myxoid/Round Cell Liposarcoma of the ExtremitiesThe American Journal of Surgical Pathology, 1996
- Liposarcoma A study of 55 cases with a reassessment of its classificationThe American Journal of Surgical Pathology, 1979